Skip to main content
. 2015 Nov 25;39(6):481–488. doi: 10.4093/dmj.2015.39.6.481

Fig. 3. (A) Glycosylated hemoglobin (HbA1c), (B) fasting blood glucose (FBG), (C) body weight, and (D) insulin dose at base, month 3 and 6 by groups. Group A: basal insulin only, group B: basal insulin+1 oral hypoglycemic agent (OHA), group C: basal insulin+≥2 OHAs, and group D: basal insulin+short acting insulin. All P values compared the difference between groups at week 24.

Fig. 3